Member Info for ciaskin

Boom-boom!

https://theconversation.com/amp/coronavirus-how-t-cells-are-involved-and-what-it-might-mean-for-vaccine-development-140374?

Ah that makes sense Berm - thanks. Together, they're quite a formidable team!

According to DE, Amanda Hayhurst facilitated the Sky coverage tonight. Interestingly, she is an independent PR practitioner and nothing to do with FTI . So it seems that they are strictly Investor Relations whereas Amanda and her company, Gloucester Road Communications, may have been behind all the recent media coverage.

Also, interesting fact - her husband is Richard Hayhurst who is Director of Communications of EASAC (European Academies Science Advisory Council). so Scancell are only a couple of steps away from this organisation, whose council membership reads like a Who's Who of European Science and Policy Makers: https://easac.eu/about-easac/council

Good find cc. (Clearly no-one here reads the paper version of the Sunday People!!) The journalist who wrote the article in the Sunday Mirror referring to, but not naming, the manufacturer that Scancell had lined up also writes for the Sunday People so I suspect she is behind this article too. Clues joining up nicely...

How soon a fiver?

Wow, wow and more WOW!!!
Well done RENX and we'll done all holders.

T'was ever thus...

Thanks for that Rats. For any of the twitterati out there, Geraldine's handle is @geraldine_mck

Brilliant find cc. Who is the Mirror journalist credited with the article?

And if FTI are worth their salt, they should know how to play it so that it doesn't appear commercial...

Of course today's media coverage may be the start of a wider political lobbying campaign. Scancell's investor relations firm, FTI Consulting, has expertise in government and public affairs too...

Great news this morning but disgraceful that ministers appear to be ignoring Lindy's pleas. Could their hand not be forced with a petition? It may need 100,000 signatures to get debated, but lobbying in this way could mobilise people and certainly bring more attention to what Scancell and Nottingham have.

https://www.parliament.uk/get-involved/sign-a-petition/e-petitions

Brilliant! Thanks Dalester (and Berm/WTP too). That did the trick.
PS. He appears just after the interview with the car dealer in the yellow tie...

Hi Bermuda. Not sure that works as the link is to the live feed with just a limited rewind. (So it may have worked around 10am but not any more). If FTI know what they are doing, hopefully it will appear on the SCLP website soon...

Ian King has a second show on Sky News at 1.30 pm so look out for a possible reprise...?

Not necessarily too much to ask, Ray. Think back to who were Scancell's partners in the CRUK Grand Challenge...

LSE rules mean we're not allowed to give out individual email addresses but the format for the company is initialsurname (at) vulpesinvest (dot) com so you can construct it from that

Scancell, the Company’s AIM quoted investment, continues to make progress, and makes up just over a sixth of the portfolio. It has announced approval to start the UK Phase 2 SCIB1 trial and has begun screening potential patients. It has also started the first joint programme on its AvidiMab anti-glycan antibody technology, having partnered with an unnamed large pharma on glycans: AvidiMab antibodies target sugars rather than proteins on the cell surface. Scancell raised £3.9 million through the issue of new shares to Vulpes Life Science Fund in June. The money will support the transition of Modi-1 to the clinic. Vulpes now owns 16.67% of Scancell – Martin Diggle from Vulpes was appointed to the board, which we believe increases the chance of a successful outcome for this investment.

Thanks Crumbs. That is quite some write up.

The deal is non-exclusive too so there could be multiple out-licensing partners in due course...a bit like an Arm Holdings scenario perhaps? (Big smile).